NCT02257853

Brief Summary

Background: \- People who have an allogeneic hematopoietic stem cell transplant (HSCT) need help as they recover. Being a caregiver can be stressful to the body and mind. Researchers want to find ways to reduce this stress. Objective: \- To see how a stress reduction intervention affects the stress levels and health of an HSCT caregiver. Eligibility: \- Adults age 18 and older who plan to be an active caregiver for a person having their first allogeneic HSCT at the NIH Clinical Center. An active caregiver is someone who will be caring for the person from just before admission for the HSCT until at least 6 weeks after. Design:

  • Participants will be put in either the intervention group or the control group.
  • All participants will get the usual caregiver education given to all patients and caregivers having a stem cell transplant at the NIH Clinical Center.
  • All participants will have 2 study visits. They will give blood samples. They will have health assessments and brief physical exams. They will fill out study questionnaires and have an exit interview.
  • The intervention group will get an MP3 player. It will have an audio file with a stress reduction intervention on it. Participants will do this intervention daily. It takes 20 minutes. They will do gentle stretches and breathing exercises. They will get a diary to track their practice.
  • The intervention group also will have follow-up phone calls 2 and 4 weeks after their first clinic visit.
  • The person getting the HSCT will not be actively involved in the study.
  • The study will last about 2 months....

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jan 2015

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 7, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

January 5, 2015

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2019

Completed
Last Updated

April 29, 2026

Status Verified

July 8, 2025

Enrollment Period

3.8 years

First QC Date

October 3, 2014

Last Update Submit

April 28, 2026

Conditions

Keywords

Caregiver StressCancer CaregiversYoga-Based Stress Reduction InterventionHSCT Caregivers

Outcome Measures

Primary Outcomes (1)

  • Perceived stress

    To examine whether HSCT caregivers participating in a stress reduction intervention demonstrate improvement in certain individual factors (self-efficacy, burden, and mindfulness), psychosocial factors (stress, anxiety, depression, loneliness, positive affect and well-being), behaviors (health behaviors) and symptoms (sleep, fatigue, depression, and cognitive impairment) compared with HSCT caregivers in the control group.

    Pre & 6 Weeks Post

Secondary Outcomes (3)

  • Cardiometabolic factors

    Pre & 6 weeks post

  • Inflammatory cytokines

    Pre & 6 Weeks Post

  • Self-reported symptoms

    Pre & 6 weeks post

Study Arms (2)

Control Group

NO INTERVENTION

No intervention group

Intervention

EXPERIMENTAL

Receives stress reduction intervention introduction with daily practice

Other: Stress reduction intervention

Interventions

Gentle chair yoga and breath work

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than or equal to 18 years old
  • Ability to comprehend the investigational nature of the study
  • Able to read and speak English
  • Agrees to participate in the study
  • Able to lift arms over head without pain
  • Able to sit and stand from a seated position unassisted
  • Intends to serve as an active caregiver\* for a patient undergoing their 1st allogeneic HSCT at the NIH Clinical Center

You may not qualify if:

  • Age less than or equal to 18 years old
  • Pregnant or lactating women
  • Inability to comprehend investigational nature of study
  • Inability to provide informed consent
  • Unable to read and speak English
  • Does not agree to participate in study or follow study design
  • Serving as a paid caregiver for any individual
  • Regular practitioner of yoga, meditation or other mind-body practice (definition: taking classes or practicing at least weekly for at least 2 of the past 6 months).
  • Physical function limitations that would interfere with intervention
  • Caregiver participants will be excluded from the biomarker analysis if they have had:
  • Glucocorticosteroid treatment in the last 2 months
  • Have a recent (within the last 2 months) acute illness or injury
  • Have served as a stem cell transplant donor or have taken filgastrim

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Publications (1)

  • Lee LJ, Shamburek R, Son H, Wallen GR, Cox R, Flynn S, Yang L, Bevans M, Wehrlen L, Ross A. Effects of a yoga-based stress reduction intervention on stress, psychological outcomes and cardiometabolic biomarkers in cancer caregivers: A randomized controlled trial. PLoS One. 2022 Nov 10;17(11):e0277009. doi: 10.1371/journal.pone.0277009. eCollection 2022.

Related Links

MeSH Terms

Conditions

Stress, PsychologicalCaregiver Burden

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Lena J Lee, Ph.D.

    National Institutes of Health Clinical Center (CC)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2014

First Posted

October 7, 2014

Study Start

January 5, 2015

Primary Completion

November 8, 2018

Study Completion

February 7, 2019

Last Updated

April 29, 2026

Record last verified: 2025-07-08

Locations